US 11066474
Anti-TrkB monoclonal antibodies and methods of use
granted A61KA61K2039/505A61K9/0019
Quick answer
US patent 11066474 (Anti-TrkB monoclonal antibodies and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K9/0019, A61P, A61P25/00